Loading organizations...
§ Private Profile · New York City, NY, USA
Healthcare vendor selection platform for software and services, offering intelligence and research for complex tech landscapes.
Elion is an intelligence and research platform that simplifies software and service vendor selection for healthcare organizations across the broader digital health sector. Operating as a specialized content-driven marketplace, the company assists healthcare builders, executives, and founders in navigating a highly complex technology landscape that currently includes over 1,300 different industry vendors. The platform provides in-depth evaluation content and strategic guidance designed to enhance procurement decision-making and accelerate overall company development timelines. To support its ongoing commercial growth, the enterprise has successfully raised $3.3 million in seed funding to expand its marketplace infrastructure, develop new insights, and scale its go-to-market operations. This initial financial backing was provided by a syndicate of notable institutional investors that includes NEA, 8VC, AlleyCorp, Charge Ventures, and Max Ventures. Elion was officially founded in 2022 by co-founders Bobby Guelich, Matt, and Lily.
Elion has raised $12.0M across 2 funding rounds.
Elion has raised $12.0M in total across 2 funding rounds.
Elion has raised $12.0M across 2 funding rounds. Most recently, it raised $9.0M Seed in August 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 1, 2025 | $9M Seed | NEA | Alumni Ventures, Arkitekt Ventures, Banana Capital, BBG Ventures, Bloom Venture Partners, General Catalyst, MAX Ventures, Lily Huang, Michael LI, NEW Enterprise Associates, OMERS Ventures, Starther, TMV, Trust Ventures, Bobby LO, AlleyCorp, Bascom Ventures, Maureen (Klewicki) Burgess, Floating Point, Christina Farr | Announced |
| Oct 1, 2022 | $3M Seed | MAX Ventures, 8VC, AlleyCorp, Charge Ventures, Floating Point, NEA | Alumni Ventures, Lily Huang, Michael LI, NEW Enterprise Associates, OMERS Ventures, TMV | Announced |
Elion is an independent digital health technology marketplace founded in 2019 and headquartered in San Francisco, California.[1][2][3] It builds a structured platform that helps healthcare organizations—including startups, established providers, and health systems—discover, evaluate, and select software vendors for areas like AI products, clinical tools, revenue cycle management, and data analytics.[1][3][6] Elion solves the challenge of fragmented vendor research by providing market maps, in-depth profiles, buyer guides, and AI-enhanced insights, enabling faster, informed IT decisions to improve healthcare delivery.[2][4][6] The company has raised $3.3 million initially and an additional $9.3 million in an oversubscribed seed round led by NEA, with backers including Max Ventures, 8VC, and others, fueling expansions like AI integration and category deep-dives.[3][6]
Elion was co-founded in 2019 by Bobby Guelich (CEO, former Head of Operations at TrialSpark and early team member at Oscar Health), Matthew Weinberg (former Executive Director at US Tech Future), and others including Lily, driven by their firsthand struggles building and investing in early-stage healthcare companies.[2][3][4] Guelich experienced the pain of rapidly standing up products without reliable vendor intel, forcing rushed decisions on unfamiliar solutions under tight timelines.[2][4] Backed by NEA and Max Ventures, who identified a market gap for an independent marketplace, Elion launched its seed-funded initial product: a content-driven platform with vendor taxonomy, discovery tools, and comparison features.[2][3] Early traction included 24 EHR vendors by mid-2023, with rapid expansions into AI-guided research.[3][6]
Elion rides the explosion of digital health tech, where healthcare builders face overwhelming vendor options amid AI adoption in personalization, automation, and data management.[1][2][6] Timing aligns with post-pandemic IT acceleration and regulatory pushes for interoperability, as providers seek efficient tools without exhaustive research.[4][6] Market forces like rising AI in revenue cycles, population health, and remote monitoring favor Elion's structured approach, reducing decision friction for startups and incumbents.[1] It influences the ecosystem by shaping shortlists, democratizing insights, and accelerating vendor adoption—helping builders deliver better care faster in a $100B+ health IT market.[2][4]
Elion is positioned to dominate as the go-to intelligence layer for health IT, with its $9.3M raise enabling deeper AI features, expanded categories, and provider-vendor network effects.[3][6] Trends like AI-driven personalization, prior authorization automation, and data interoperability will propel growth, as health systems prioritize scalable tech amid labor shortages.[6] Its influence may evolve into a full decision platform, potentially powering enterprise RFPs and M&A diligence, solidifying Elion as the indispensable navigator in digital health's complexity. This addresses the core pain from its origins: empowering builders to innovate without vendor-hunt hurdles.[2][4]
Elion has raised $12.0M in total across 2 funding rounds.
Elion's investors include Michael Li, Alumni Ventures, Arkitekt Ventures, Banana Capital, BBG Ventures, bloom venture partners, General Catalyst, Max Ventures, Lily Huang, New Enterprise Associates, OMERS Ventures, StartHer.